RFK Jr.'s Nomination to Head Health Department Will Shake Up Vaccine Landscape -- Market Talk

Dow Jones11-15

1122 GMT - Robert F. Kennedy Jr.'s nomination as Health and Human Services secretary will likely impact vaccine makers and the Food and Drug Administration, Jefferies analysts write. Kennedy has publicly criticized childhood and mRNA-based vaccines, the analysts say. Vaccine perception in the U.S. could suffer, leading to lower demand and sales and potentially cause outbreaks if vaccinations are not consistent over the next four years, Jefferies says. Kennedy has also been vocal on overhauling the FDA, which could alter the regulatory path, resources for biotech and drug review positions as well as impacting key FDA leadership. Bavarian Nordic shares are down 16%, with Valneva down 6%. (dominic.chopping@wsj.com)

(END) Dow Jones Newswires

November 15, 2024 06:22 ET (11:22 GMT)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2483329582?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-11-15 19:22","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2483329582","market":"sh","top_or_hot":-1,"title":"RFK Jr.'s Nomination to Head Health Department Will Shake Up Vaccine Landscape -- Market Talk","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n     1122 GMT - Robert F. Kennedy Jr.'s nomination as Health and Human Services secretary will likely impact vaccine makers and the Food and Drug Administration, Jefferies analysts write. Kennedy has publicly criticized childhood and mRNA-based vaccines, the analysts say. Vaccine perception in the U.S. could suffer, leading to lower demand and sales and potentially cause outbreaks if vaccinations are not consistent over the next four years, Jefferies says. Kennedy has also been vocal on overhauling the FDA, which could alter the regulatory path, resources for biotech and drug review positions as well as impacting key FDA leadership. Bavarian Nordic shares are down 16%, with Valneva down 6%. (dominic.chopping@wsj.com) \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  November 15, 2024 06:22 ET (11:22 GMT)\n</p>\n<p>\n  Copyright (c) 2024 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>RFK Jr.'s Nomination to Head Health Department Will Shake Up Vaccine Landscape -- Market Talk</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nRFK Jr.'s Nomination to Head Health Department Will Shake Up Vaccine Landscape -- Market Talk\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-11-15 19:22 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://dowjonesnews.com/newdjn/logon.aspx?AL=N><strong>Dow Jones</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>1122 GMT - Robert F. Kennedy Jr.'s nomination as Health and Human Services secretary will likely impact vaccine makers and the Food and Drug Administration, Jefferies analysts write. Kennedy has ...</p>\n\n<a href=\"https://dowjonesnews.com/newdjn/logon.aspx?AL=N\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"VALN","symbol_name":"Valneva SE","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2483329582","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2483329582","pubTimestamp":1731669720,"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"1122 GMT - Robert F. Kennedy Jr.'s nomination as Health and Human Services secretary will likely impact vaccine makers and the Food and Drug Administration, Jefferies analysts write. Kennedy has publicly criticized childhood and mRNA-based vaccines, the analysts say. Vaccine perception in the U.S. could suffer, leading to lower demand and sales and potentially cause outbreaks if vaccinations are not consistent over the next four years, Jefferies says. Kennedy has also been vocal on overhauling the FDA, which could alter the regulatory path, resources for biotech and drug review positions as well as impacting key FDA leadership. Bavarian Nordic shares are down 16%, with Valneva down 6%. ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"VALN":"Valneva SE","BK4139":"生物科技","BK4539":"次新股"},"translate_title":"小RFK被提名为卫生部门负责人将改变疫苗格局——市场讨论","themeId":"8b50228a679c44f870e44bbf889089f6","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"VALN":0.9},"content_text":"1122 GMT - Robert F. Kennedy Jr.'s nomination as Health and Human Services secretary will likely impact vaccine makers and the Food and Drug Administration, Jefferies analysts write. Kennedy has publicly criticized childhood and mRNA-based vaccines, the analysts say. Vaccine perception in the U.S. could suffer, leading to lower demand and sales and potentially cause outbreaks if vaccinations are not consistent over the next four years, Jefferies says. Kennedy has also been vocal on overhauling the FDA, which could alter the regulatory path, resources for biotech and drug review positions as well as impacting key FDA leadership. Bavarian Nordic shares are down 16%, with Valneva down 6%. (dominic.chopping@wsj.com) \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  November 15, 2024 06:22 ET (11:22 GMT)\n\n\n  Copyright (c) 2024 Dow Jones & Company, Inc.","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2483329582"}